LC

Lightswitch Capital

North America, New York, United States, New York

Description

Lightswitch Capital is a venture capital firm.

Investor Profile

Lightswitch Capital has made 4 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Series C (50%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Artificial Intelligence (Ai)
  • Biopharma
  • Neuroscience
  • Precision Medicine
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lightswitch Capital frequently co-invest with?

Bluebird Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Alkeon Capital
North America, New York, United States, New York
Co-Investments: 2
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
CAM Capital
North America, New York, United States, New York
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
IC
North America, Illinois, United States, Chicago
Co-Investments: 2
Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Lightswitch Capital?

Hinge Bio

Burlingame, California, United States

Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.

BiotechnologyLife ScienceMedical
Series AJan 15, 2025
Amount Raised: $30,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series CNov 21, 2023
Amount Raised: $45,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series BOct 25, 2022
Amount Raised: $35,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series CMay 16, 2022
Amount Raised: $270,000,000